278 related articles for article (PubMed ID: 25457157)
1. Prognostic significance of promyelocytic leukemia expression in gastrointestinal stromal tumor; integrated proteomic and transcriptomic analysis.
Ichikawa H; Yoshida A; Kanda T; Kosugi S; Ishikawa T; Hanyu T; Taguchi T; Sakumoto M; Katai H; Kawai A; Wakai T; Kondo T
Cancer Sci; 2015 Jan; 106(1):115-24. PubMed ID: 25457157
[TBL] [Abstract][Full Text] [Related]
2. Clinicopathological and Prognostic Significance of Expression of B-Cell-Specific Moloney Murine Leukemia Virus Insertion Site 1 (BMI-1) Gene and Protein in Gastrointestinal Stromal Tumors.
Zhu K; Li K; Yuan DW; Xu G; Kang L; Dang CX; Zhang Y
Med Sci Monit; 2018 Sep; 24():6414-6421. PubMed ID: 30209248
[TBL] [Abstract][Full Text] [Related]
3. SLITRK3 expression correlation to gastrointestinal stromal tumor risk rating and prognosis.
Wang CJ; Zhang ZZ; Xu J; Wang M; Zhao WY; Tu L; Zhuang C; Liu Q; Shen YY; Cao H; Zhang ZG
World J Gastroenterol; 2015 Jul; 21(27):8398-407. PubMed ID: 26217092
[TBL] [Abstract][Full Text] [Related]
4. PML protein as a prognostic molecular marker for patients with esophageal squamous cell carcinomas receiving primary surgery.
Yen CC; Tsao YP; Chen PC; Wu YC; Liu JH; Pan CC; Liu CY; Tzeng CH; Chen PM; Chen YJ; Lin CH; Hsu WH
J Surg Oncol; 2011 Jun; 103(8):761-7. PubMed ID: 21240990
[TBL] [Abstract][Full Text] [Related]
5. Identification of low-density lipoprotein receptor class A domain containing 4 (LDLRAD4) as a prognostic indicator in primary gastrointestinal stromal tumors.
Xie W; Xiao H; Luo J; Zhao L; Jin F; Ma J; Li J; Xiong K; Chen C; Wang G
Curr Probl Cancer; 2020 Dec; 44(6):100593. PubMed ID: 32507364
[TBL] [Abstract][Full Text] [Related]
6. Prognostic value of Rab27B nuclear expression in gastrointestinal stromal tumors.
Wang W; Ni Q; Wang H; Zhang S; Zhu H
Dis Markers; 2014; 2014():942181. PubMed ID: 25382899
[TBL] [Abstract][Full Text] [Related]
7. Evaluation of malignancy using Ki-67, p53, EGFR and COX-2 expressions in gastrointestinal stromal tumors.
Jiang J; Jin MS; Suo J; Wang YP; He L; Cao XY
World J Gastroenterol; 2012 May; 18(20):2569-75. PubMed ID: 22654456
[TBL] [Abstract][Full Text] [Related]
8. Low ETV1 mRNA expression is associated with recurrence in gastrointestinal stromal tumors.
Sakamaki K; Funasaka K; Miyahara R; Furukawa K; Yamamura T; Ohno E; Nakamura M; Kawashima H; Hirooka Y; Fujishiro M; Goto H
Sci Rep; 2020 Sep; 10(1):14767. PubMed ID: 32901065
[TBL] [Abstract][Full Text] [Related]
9. Expression and clinicopathological significance of CD9 in gastrointestinal stromal tumor.
Yang H; Shen C; Zhang B; Chen H; Chen Z; Chen J
J Korean Med Sci; 2013 Oct; 28(10):1443-8. PubMed ID: 24133347
[TBL] [Abstract][Full Text] [Related]
10. Prognostic angiogenic markers (endoglin, VEGF, CD31) and tumor cell proliferation (Ki67) for gastrointestinal stromal tumors.
Basilio-de-Oliveira RP; Pannain VL
World J Gastroenterol; 2015 Jun; 21(22):6924-30. PubMed ID: 26078569
[TBL] [Abstract][Full Text] [Related]
11. HAND1 and BARX1 Act as Transcriptional and Anatomic Determinants of Malignancy in Gastrointestinal Stromal Tumor.
Hemming ML; Coy S; Lin JR; Andersen JL; Przybyl J; Mazzola E; Abdelhamid Ahmed AH; van de Rijn M; Sorger PK; Armstrong SA; Demetri GD; Santagata S
Clin Cancer Res; 2021 Mar; 27(6):1706-1719. PubMed ID: 33451979
[TBL] [Abstract][Full Text] [Related]
12. Promyelocytic leukemia (PML) gene expression is a prognostic factor in ampullary cancer patients.
Vincenzi B; Santini D; Perrone G; Russo A; Adamo V; Rizzo S; Castri F; Antinori A; Alloni R; Crucitti PF; Morini S; Rabitti C; Vecchio FM; Magistrelli P; Coppola R; Tonini G
Ann Oncol; 2009 Jan; 20(1):78-83. PubMed ID: 18689862
[TBL] [Abstract][Full Text] [Related]
13. Prognostic Relevance of p53 Overexpression in Gastrointestinal Stromal Tumors of the Small Intestine: Potential Implication for Adjuvant Treatment with Imatinib.
Yoo C; Koh YW; Park YS; Ryu MH; Ryoo BY; Park HJ; Yook JH; Kim BS; Kang YK
Ann Surg Oncol; 2015 Dec; 22 Suppl 3():S362-9. PubMed ID: 25791792
[TBL] [Abstract][Full Text] [Related]
14. [Prognostic significance of clinicopathologic parameters in gastrointestinal stromal tumor: a study of 156 cases].
Liang YM; Li XH; Lü YY; Lü YL; Zhong M; Pu XL; Li WM
Zhonghua Bing Li Xue Za Zhi; 2007 Apr; 36(4):233-8. PubMed ID: 17706113
[TBL] [Abstract][Full Text] [Related]
15. Association of high expression of Groβ with clinical and pathological characteristics of unfavorable prognosis in gastrointestinal stromal tumors.
Zhao H; Zhu H; Jin Q; Zhang S; Wang W; Wang D; Huang J
Dis Markers; 2015; 2015():171035. PubMed ID: 25944970
[TBL] [Abstract][Full Text] [Related]
16. Comparison of Gene Expression Profile Between Tumor Tissue and Adjacent Non-tumor Tissue in Patients with Gastric Gastrointestinal Stromal Tumor (GIST).
Kou Y; Zhao Y; Bao C; Wang Q
Cell Biochem Biophys; 2015 Jun; 72(2):571-8. PubMed ID: 25586720
[TBL] [Abstract][Full Text] [Related]
17. Use of potassium channel tetramerization domain-containing 12 as a biomarker for diagnosis and prognosis of gastrointestinal stromal tumor.
Hasegawa T; Asanuma H; Ogino J; Hirohashi Y; Shinomura Y; Iwaki H; Kikuchi H; Kondo T
Hum Pathol; 2013 Jul; 44(7):1271-7. PubMed ID: 23290008
[TBL] [Abstract][Full Text] [Related]
18. Transcriptomic reappraisal identifies MGLL overexpression as an unfavorable prognosticator in primary gastrointestinal stromal tumors.
Li CF; Chuang IC; Liu TT; Chen KC; Chen YY; Fang FM; Li SH; Chen TJ; Yu SC; Lan J; Huang HY
Oncotarget; 2016 Aug; 7(31):49986-49997. PubMed ID: 27366945
[TBL] [Abstract][Full Text] [Related]
19. Fascin-1 overexpression and miR-133b downregulation in the progression of gastrointestinal stromal tumor.
Yamamoto H; Kohashi K; Fujita A; Oda Y
Mod Pathol; 2013 Apr; 26(4):563-71. PubMed ID: 23196799
[TBL] [Abstract][Full Text] [Related]
20. Pfetin as a risk factor of recurrence in gastrointestinal stromal tumors.
Orita H; Ito T; Kushida T; Sakurada M; Maekawa H; Wada R; Suehara Y; Kubota D; Sato K
Biomed Res Int; 2014; 2014():651935. PubMed ID: 24977158
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]